(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.38%) $79.29
(-0.27%) $2.18
(-0.28%) $2 315.70
(-0.22%) $27.54
(0.01%) $984.70
(0.07%) $0.931
(0.16%) $10.91
(0.05%) $0.801
(0.01%) $91.74
4 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 5.04%
Live Chart Being Loaded With Signals
Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery, minimal access/laparoscopic surgery, urology, gastroenterology, and aesthetic and reconstructive surgery...
Stats | |
---|---|
本日の出来高 | 1.30M |
平均出来高 | 3.12M |
時価総額 | 781.51B |
EPS | INR0 ( 2024-01-30 ) |
次の収益日 | ( INR0 ) 2024-05-13 |
Last Dividend | INR1.000 ( 2023-09-08 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 73.84 |
ATR14 | INR1.722 (0.21%) |
ボリューム 相関
Max Healthcare Institute 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Max Healthcare Institute 相関 - 通貨/商品
Max Healthcare Institute 財務諸表
Annual | 2022 |
収益: | INR45.63B |
総利益: | INR36.41B (79.79 %) |
EPS: | INR11.38 |
FY | 2022 |
収益: | INR45.63B |
総利益: | INR36.41B (79.79 %) |
EPS: | INR11.38 |
FY | 2022 |
収益: | INR38.83B |
総利益: | INR29.60B (76.23 %) |
EPS: | INR6.25 |
FY | 2021 |
収益: | INR24.82B |
総利益: | INR18.88B (76.06 %) |
EPS: | INR-1.590 |
Financial Reports:
No articles found.
Max Healthcare Institute Dividends
(Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR1.000 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR1.000 | 2023-09-08 |
Last Dividend | INR1.000 | 2023-09-08 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | INR1.000 | -- |
Avg. Dividend % Per Year | 0.07% | -- |
Score | 1.23 | -- |
Div. Sustainability Score | 4.11 | |
Div.Growth Potential Score | 3.85 | |
Div. Directional Score | 3.98 | -- |
Year | Amount | Yield |
---|---|---|
2023 | INR1.000 | 0.22% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PRECWIRE.NS | Dividend Junior | 2023-08-28 | Semi-Annually | 23 | 1.28% | |
KALYANIFRG.NS | Dividend Junior | 2023-09-13 | Annually | 17 | 0.81% | |
DYNAMATECH.NS | Dividend Junior | 2023-06-09 | Sporadic | 17 | 0.10% | |
ADFFOODS.NS | Dividend Junior | 2023-08-03 | Sporadic | 14 | 1.83% | |
STEELCAS.NS | Dividend Knight | 2023-08-14 | Bi-Monthly | 3 | 0.88% | |
MURUDCERA.NS | Dividend Junior | 2023-09-14 | Sporadic | 21 | 0.33% | |
HINDCOPPER.NS | Dividend Junior | 2023-09-22 | Sporadic | 15 | 0.47% | |
BPCL.NS | Dividend Knight | 2023-08-11 | Semi-Annually | 29 | 3.25% | |
RELIANCE.NS | Dividend Knight | 2023-08-21 | Annually | 29 | 0.24% | |
KRITINUT.NS | No Dividend Player | 2023-08-21 | Insufficient data to determine frequency | 2 | 0.17% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.203 | 1.500 | 5.94 | 8.90 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.139 | 1.500 | 9.57 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 22.96 | 1.000 | 2.61 | 2.61 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.95 | 2.00 | 8.68 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.95 | 2.00 | 8.03 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.833 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.259 | 1.000 | 6.82 | 6.82 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 73.92 | 1.000 | 2.63 | 0 | [1 - 100] |
returnOnEquityTTM | 0.139 | 2.50 | 9.72 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.95 | 2.00 | 8.68 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.124 | 1.500 | 6.89 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.95 | 2.00 | 8.68 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.150 | 1.500 | -2.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0738 | 1.000 | -0.656 | 0 | [0.1 - 0.5] |
Total Score | 3.85 |
Max Healthcare Institute
Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery, minimal access/laparoscopic surgery, urology, gastroenterology, and aesthetic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. As of August 27, 2021, it operated a network of 17 healthcare facilities, including tertiary and quaternary care hospitals at Saket, Patparganj, Vaishali, Rajendra Place, and Shalimar Bagh in Delhi National Capital Region; one each in Mumbai, Mohali, Bathinda, and Dehradun; a secondary care hospital in Gurugram; and day care centres at Noida, Lajpat Nagar, and Panchsheel Park in Delhi National Capital Region and one in Mohali, Punjab. The company is based in Gurugram, India.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。